India to Afghanistan: Sorafenib Export Trade Route
India has recorded 19 verified shipments of Sorafenib exported to Afghanistan, representing a combined trade value of $174.7K USD. This corridor is served by 8 active Indian exporters, with an average shipment value of $9.2K USD. The leading Indian exporter is MEDYRA PHARMACEUTICAL, which accounts for 80% of total export value with 6 shipments worth $139.4K USD. On the buying side, BY THE ORDER OF is the largest importer in Afghanistan with $135.6K USD in purchases. The top 3 suppliers — MEDYRA PHARMACEUTICAL, KWALITY PHARMACEUTICALS LIMITED, SARTAJ PHARMA PRIVATE LIMITED — together control 95% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Afghanistan Sorafenib corridor is one of India's established pharmaceutical export routes, with 19 shipments documented worth a combined $174.7K USD. The route is dominated by MEDYRA PHARMACEUTICAL, which alone accounts for roughly 80% of all export value, reflecting the consolidated nature of India's sorafenib manufacturing sector.
Across 8 active suppliers, the average shipment value stands at $9.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 23.2%, placing it at rank #5 among India's top sorafenib export destinations globally.
On the import side, key buyers of Indian sorafenib in Afghanistan include BY THE ORDER OF, TRUST ANESTHETIC LTD, SARTAJ ENTERPRIESES LIMITED and 8 others. BY THE ORDER OF is the single largest importer with 1 shipments valued at $135.6K USD.
Route Characteristics
- Average transit34 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top portDELHI AIR
Market Position
- Global rank#5
- Annual growth+23.2%
- Demand growth+21.4%
- Regulatory ease70/100
Top 10 Indian Sorafenib Exporters to Afghanistan
Showing top 10 of 8 Indian suppliers exporting Sorafenib to Afghanistan, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MEDYRA PHARMACEUTICAL Avg $23.2K per shipment | 6 | $139.4K | 79.8% |
| 2 | KWALITY PHARMACEUTICALS LIMITED Avg $4.9K per shipment | 3 | $14.6K | 8.4% |
| 3 | SARTAJ PHARMA PRIVATE LIMITED Avg $2.9K per shipment | 4 | $11.6K | 6.6% |
| 4 | SARTAJ PHARMA PRIVATE LIMITED Avg $2.2K per shipment | 2 | $4.3K | 2.5% |
| 5 | KERK Avg $2.0K per shipment | 1 | $2.0K | 1.1% |
| 6 | MBA PHARMACEUTICALS PRIVATE LIMITED Avg $1.5K per shipment | 1 | $1.5K | 0.8% |
| 7 | RESCUERS LIFE SCIENCES LIMITED Avg $1.3K per shipment | 1 | $1.3K | 0.7% |
| 8 | BETA DRUGS LIMITED Avg $24 per shipment | 1 | $24 | 0.0% |
This table shows the top 10 of 8 Indian companies exporting sorafenib to Afghanistan, ranked by total trade value. The listed exporters are: MEDYRA PHARMACEUTICAL, KWALITY PHARMACEUTICALS LIMITED, SARTAJ PHARMA PRIVATE LIMITED, SARTAJ PHARMA PRIVATE LIMITED , KERK, MBA PHARMACEUTICALS PRIVATE LIMITED, RESCUERS LIFE SCIENCES LIMITED, BETA DRUGS LIMITED. MEDYRA PHARMACEUTICAL is the dominant supplier with 6 shipments worth $139.4K USD, giving it a 80% market share. The top 3 suppliers together account for 95% of the total trade value on this route.
Top 10 Sorafenib Importers in Afghanistan
Showing top 10 of 11 known buyers in Afghanistan receiving Sorafenib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian sorafenib in Afghanistan include BY THE ORDER OF, TRUST ANESTHETIC LTD, SARTAJ ENTERPRIESES LIMITED, SARTAJ ENTERPRIESES LIMITED , BY THE ORDER OF :, among 11 total buyers. The largest importer is BY THE ORDER OF, accounting for $135.6K USD across 1 shipments — representing 78% of all sorafenib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BY THE ORDER OF | 1 | $135.6K | 77.6% |
| 2 | TRUST ANESTHETIC LTD | 3 | $14.6K | 8.4% |
| 3 | SARTAJ ENTERPRIESES LIMITED | 4 | $11.6K | 6.6% |
| 4 | SARTAJ ENTERPRIESES LIMITED | 2 | $4.3K | 2.5% |
| 5 | BY THE ORDER OF : | 3 | $2.6K | 1.5% |
| 6 | ZABI | 1 | $2.0K | 1.1% |
| 7 | TO., | 1 | $1.5K | 0.8% |
| 8 | ETEMED MOSLEH LIMITED | 1 | $1.3K | 0.7% |
| 9 | BY THE ORDER OF MUHAMMAD WARES SAFAI CO | 1 | $929 | 0.5% |
| 10 | QAIS HOTAK LTD. | 1 | $311 | 0.2% |
Showing top 10 of 11 Sorafenib importers in Afghanistan on this route.
Top 10 Sorafenib Formulations Imported by Afghanistan
Showing top 10 of 16 product formulations shipped on the India to Afghanistan Sorafenib route, ranked by trade value
Afghanistan imports a wide range of sorafenib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — SORAFYRA-200 SORAFENIB 200MG TABLETS(1X30TABS,560BTL)(T23SF10A3 M.01-10-2023 E.30-09-2025) — accounts for $135.6K USD across 1 shipments. There are 16 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SORAFYRA-200 SORAFENIB 200MG TABLETS(1X30TABS,560BTL)(T23SF10A3 M.01-10-2023 E.30-09-2025) | 1 | $135.6K | 77.6% |
| 2 | HARMLESS MEDICINES FOR HUMAN USE -SORAFENIB TABLETS 200MG (OTHER DETAILS ASPER INVOICE)NOS | 3 | $14.6K | 8.4% |
| 3 | PHARMA PRODUCT- SORATAJ 200 MG [EACH FILM COATED TABLET CONTAINS SORAFENIB TOSYLATE IP EQ. TO SORAFENIB 200 MG EXCIPIENT | 2 | $6.1K | 3.5% |
| 4 | PHARMA PRODUCT- SORATAJ 200 MG EACH FILMCOATED TABLET CONTAINS SORAFENIB TOSYLATE IP EQ. TO SORAFENIB 200 MG EXCIPIENTS | 1 | $2.8K | 1.6% |
| 5 | SORATAJ 200 MG TABLET CONTAINS SORAFENIBTOSYLATE IP EQ. TO SORAFENIB 200 MG EXCIPIENTS QS B,NO.AS3FT306Z MFG.12/2023 ENOS | 1 | $2.7K | 1.6% |
| 6 | PHARMA PRODUCT- SORATAJ 200 MG SORAFENIB | 1 | $2.2K | 1.2% |
| 7 | PHARMA PRODUCT SORATAJ 200 MG SORAFENIB | 1 | $2.2K | 1.2% |
| 8 | SORALIB TABLET [SORAFENIB TOSYLATE IP EQTO SORAFENIB 200MG EXCIPIENTS Q.S] B.NO: SPOT230020 MFD:8/2023 EXP: 7/2025 | 1 | $2.0K | 1.1% |
| 9 | PHARMA PRODUCTS-(Sorafenib Tablets IP 200mg)-B.NO-ACT2311SF,MFG-FEB-24,EXP-JAN-26 | 1 | $1.5K | 0.8% |
| 10 | RESNIB TABLETS GENERIC NAME: SORAFENIB TOSYLATE TABLETS 200MG, PACK SIZE: , BATCH NO RO24065T1 ,MFG.DT.11/2024 | 1 | $1.3K | 0.7% |
Showing top 10 of 16 Sorafenib formulations imported by Afghanistan on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 69% sea for bulk, 18% air for urgent orders.
Top Ports of Origin
DELHI AIR handles the highest volume with 4 shipments. Transit time averages 34 days by sea.
Market Dynamics
India's sorafenib exports to Afghanistan are driven primarily by a handful of large-scale manufacturers. MEDYRA PHARMACEUTICAL with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in Afghanistan benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MEDYRA PHARMACEUTICAL, KWALITY PHARMACEUTICALS LIMITED, SARTAJ PHARMA PRIVATE LIMITED — together account for 95% of total trade value on this route. The average shipment value of $9.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicines for human use -sorafenib tablets 200mg (other details asper invoice)nos and pharma product- sorataj 200 mg [each film coated tablet contains sorafenib tosylate ip eq. to sorafenib 200 mg excipient, suggesting that buyers in Afghanistan tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, BY THE ORDER OF is the largest importer with 1 shipments worth $135.6K USD — representing 78% of all sorafenib imports from India on this route. A total of 11 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $174.7K
- Avg. Shipment
- $9.2K
- Suppliers
- 8
- Buyers
- 11
- Transit (Sea)
- ~34 days
- Annual Growth
- +23.2%
Other Sorafenib Routes
Unlock the Full India to Afghanistan Sorafenib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 19 shipments on this route.
Frequently Asked Questions — India to Afghanistan Sorafenib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Sorafenib to Afghanistan?
The leading Indian exporters of Sorafenib to Afghanistan are MEDYRA PHARMACEUTICAL, KWALITY PHARMACEUTICALS LIMITED, SARTAJ PHARMA PRIVATE LIMITED. MEDYRA PHARMACEUTICAL holds the largest market share at approximately 80% of total trade value on this route.
Q What is the total value of Sorafenib exports from India to Afghanistan?
India exports Sorafenib to Afghanistan worth approximately $174.7K USD across 19 recorded shipments. The average value per shipment is $9.2K USD.
Q Which ports does India use to ship Sorafenib to Afghanistan?
The most active port of origin is DELHI AIR with 4 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 69% of shipments going by sea and 18% by air.
Q How long does shipping take from India to Afghanistan for Sorafenib?
The average transit time for Sorafenib shipments from India to Afghanistan is approximately 34 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Afghanistan Sorafenib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 23.2% with demand growth tracking at 21.4%. The route is ranked #5 among India's top Sorafenib export destinations globally.
Q How many suppliers are active on the India to Afghanistan Sorafenib route?
There are currently 8 active Indian suppliers exporting Sorafenib to Afghanistan. The market is moderately concentrated with MEDYRA PHARMACEUTICAL accounting for 80% of total shipment value.
Q Who are the main importers of Sorafenib from India in Afghanistan?
The leading importers of Indian Sorafenib in Afghanistan include BY THE ORDER OF, TRUST ANESTHETIC LTD, SARTAJ ENTERPRIESES LIMITED, SARTAJ ENTERPRIESES LIMITED , BY THE ORDER OF :. BY THE ORDER OF is the largest buyer with 1 shipments worth $135.6K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Afghanistan export trade corridor identified from Indian Customs (DGFT) records for Sorafenib.
- 2.Supplier/Buyer Matching: 8 Indian exporters and 11 importers in Afghanistan matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 19 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
19 Verified Shipments
8 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists